We studied 40 patients with stroke of potential cardioembolic origin by cardiac ultrafast computed tomography and two-dimensional echocardiography. Cardiac ultrafast computed tomography was more sensitive (positive in eight of 14 instances) than two-dimensional echocardiography (positive in two of 14 instances) for the detection of intracardiac thrombus, which was found in 13 patients. Mitral anular calcification was diagnosed more often by two-dimensional echocardiography (four of five instances) than by cardiac ultrafast computed tomography (one of five instances); this implies a high incidence of false-positives for the former. 
T he heart may not only provide a source of embolus for stroke but may also be the target organ for more widespread vascular disease such as coronary artery atheroma. 12 The latter not only suggests coexistent atheromatous involvement of the brain vasculature but also carries prognostic significance for the incidence and outcome of cerebral ischemia. 3 -5 Accurate detection of cardiovascular pathology provides the ability to make rational diagnostic and therapeutic decisions for preventing further cerebrovascular accidents and for improving stroke outcome.
Short of necropsy or intraoperative confirmation, proof of a cardiac origin for thromboembolism and coronary artery atheroma is indirect and is derived from a combination of history and the findings of less invasive imaging and rhythm monitoring techniques.
In addition to the clinical history, various methods are used to detect cardiac pathology. One of the most recent methods is computed tomography (CT) of the heart. Two-dimensional echocardiography (2D echo) and electrocardiography (ECG) are less-than-perfect means for defining intracardiac thrombus, myocardial infarction (MI), or the presence of coronary artery disease (CAD). We present the findings of cardiac ultrafast computed tomography (UFCT) in 40 patients with ischemic stroke as they relate to cardiac-origin embolism and the presence of CAD.
Subjects and Methods
Over 1 year, cardiac UFCT and ECG were performed in 40 patients with stroke; 38 underwent 2D echo. We used an Imatron C-100 UFCT scanner (South San Francisco, California) that employs an electron beam generated from a cathode above the patient's head. The beam is magnetically deflected to four tungsten target rings below the patient's thorax to create a fan of x-rays sensed above the patient by stationary detectors that are coupled with a data processing system to convert the data to an image. Cardiac UFCT scans are obtained by two imaging modes (flow and cine) after iodinated contrast medium is injected into a peripheral superficial vein. The flow mode gates scanning to the ECG R wave so the heart is always imaged at the same point of the cardiac cycle and is used to evaluate transit of the bolus of contrast medium through the chambers. The cine mode scans are triggered by the ECG R wave, and scanning is continuous (50 msec/ scan) for one entire cardiac cycle. Contraindications to scanning are known allergy to contrast medium, renal failure, and pregnancy. Advantages of cardiac UFCT are its rapid scan acquisition time and the absence of motion artifacts, resulting in clear images of excellent spatial resolution (1.5 mm).
Three experienced cardiologists blinded to the patient's 2D echo or ECG results independently interpreted and recorded the cardiac UFCT. Three cardiologists independently reviewed the 2D echo done at the time of UFCT and within 21 days of the patient's stroke. The consensus of at least two of the three cardiologists determined the recorded result. The ECG results were taken from the official ECG laboratory report read by a cardiologist unaware of the cardiac UFCT or 2D echo results.
Each patient was examined by the same neurologist, and each CT head scan was interpreted by the same radiologist.
The mean age of the patients was 61 (range 18-86) years; all patients were scanned within 21 days of stroke onset. Between stroke onset and cardiac UFCT and 2D echo, no further ischemic events occurred. In each patient, a thromboembolic source for the stroke was suspected either clinically due to the sudden onset of neurologic deficit or due to the findings of head CT. Stroke type defined by conventional head CT was most often unilateral, moderate to large in size, or multiple and bilateral and in the middle cerebral artery territory. Four retinal occlusions were included in our patient series (Table 1) .
Pathologic confirmation of the findings of cardiac UFCT and 2D echo was not available as no patient in our series died. By UFCT, thrombus was defined as a filling defect within a cavity not attributable to a partial volume effect or to normal anatomy (Figures 1 and 2). A partial volume effect of the left atrial (LA) appendage and normal left ventricular (LV) papillary muscles can be misconstrued as thrombus; however, experienced observers can usually make these distinctions when examining findings in the context of a total cardiac study. For our purposes, the filling defect must have been seen at more than one UFCT level or in both flow and cine modes to diagnose thrombus. Thrombus was defined by 2D echo as a mass of echoes in at least two views of the cardiac cavity, seen throughout the cardiac cycle, contiguous with the cardiac wall. By UFCT and 2D echo, focal wall dyskinesia (FWD) was defined as an area of abnormal LV wall thickening LA appendager clot and thinning with decreased motion. MI was defined as a region of abnormally thin myocardium throughout the cardiac cycle and associated with abnormal motion. Dilated cardiomyopathy was diagnosed when a dilated LV was found with globally decreased wall motion (GWD). By UFCT, mitral anular calcification (MAC) and coronary artery calcification (CAC) were defined as areas of calcium density in the appropriate locations ( Figure 3) . By 2D echo, MAC was defined as a band of abnormal high-density echoes between the mitral valve and the posterior LV wall at the mitral anulus. By ECG, MI was defined as the presence of Q waves lasting >35 msec.
Results Thirty-three of the 40 patients scanned by cardiac UFCT had evidence of either a thromboembolism source or CAD as defined by UFCT, 2D echo, or ECG (Table 2) ; two patients did not undergo 2D echo.
Intracardiac thrombus was identified in 13 of the 40 patients (Table 2) : LV in five and LA in nine; one patient had thrombus at both sites. In no instance was LV thrombus diagnosed by both UFCT and 2D echo. LA thrombus was diagnosed in seven patients by UFCT alone and in two patients by 2D echo alone; discordance existed in seven instances.
Twenty-one of the 40 patients had CAD as defined by the presence of CAC on UFCT. In the presence of CAC, MI was diagnosed in 10 of the 21 patients (six times by UFCT, twice by 2D echo, and six times by ECG). In the absence of CAC, MI was identified in four of the 19 patients (three times by UFCT, once by 2D echo, and once by ECG).
Eleven of the 40 patients had FWD (six of the 21 with CAC) and three had GWD (one of the 21 with CAC). There was concordance with regard to wall dyskinesis between UFCT and 2D echo in three patients and discordance in eight, with UFCT having greater sensitivity.
Of the five patients with LV thrombus, three had evidence of MI, two of FWD, and one of GWD. One patient with LV thrombus had no evidence of either wall dyskinesis or MI.
MAC was identified in five patients (twice by UFCT and four times by 2D echo). In only one of the five patients with MAC was there concordance between UFCT and 2D echo.
Of 38 2D echo studies, 16 were judged by at least two cardiologists to be technically inadequate for interpreting thrombus, regional wall motion abnormality, MI, or MAC. UFCT scans were incomplete in four of the 40 patients, preventing interpretation of at least one of the above conditions. Incomplete UFCT studies were due to failure to scan all areas of interest in both modes.
Discussion
Debate exists on whether to evaluate the heart routinely for a source of embolus in patients with stroke. 26 Despite estimates of potential cardiac sources of embolus ranging from 3% to 55% for patients with stroke, attempts have been made to justify eliminating cardiac investigation in patients who may or may not have evidence for an arterial source of thromboembolism. 7 - 13 Recent data suggest that definite clinical criteria for distinguishing cardiac and arterial sources of embolic stroke do not exist FIGURE 
Left anterior descending (located more anteriorly) and circumflex coronary artery calcification on ultrafast computed tomogram. Image is viewed from below, looking toward patient's head.
and that investigation of both emboligenic territories may reveal a pathogenic thrombus nidus in the heart regardless of the results of arterial studies. 61415 There are reports of the utility of various noninvasive methods to detect cardiac sources of thromboembolism in stroke patients. 16 -20 Our study is the first to describe the findings of UFCT in such patients. 21 We evaluated patients whose history and results of head CT suggested cardioembolic stroke. The high proportion of patients harboring intracardiac thrombi (13 of 40) visualized by UFCT and 2D echo probably reflects our patient selection.
UFCT appeared to be the more sensitive method for detecting thrombus in both LV and LA. Even when 2D echo studies of patients with intracardiac clot by UFCT were reviewed a second time and UFCT results were known, no evidence for thrombus could be found. Tomoda et al 22 -24 and other researchers 2526 have reported the superiority of conventional cardiac CT in detecting LV apical and LA appendage thrombus. Tomoda et al 22 confirmed the accuracy of CT by surgical inspection. Although our study does not have the strength of pathologic confirmation of intracardiac thrombus, it also suggests that UFCT is much more sensitive (eight of 14 instances) than 2D echo (two of 14 instances).
Two-dimensional echocardiography has difficulty revealing the LV apex and LA appendage. 27 
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29 Furthermore, 2D echo has limited use when pulmonary disease, abnormal body habitus, and obesity are present. The advantage of UFCT is that it provides images of the heart in areas difficult to view by 2D echo without being limited by surrounding tissue artifacts. 22 -2630 - 32 Bansal et al 33 reported a 25% incidence of technically inadequate 2D echo studies. Our larger proportion of technically limited 2D echo studies (42%) is not dissimilar to that described by Beattie et al 34 (34%) and may be explained by our patient population. Two-dimensional echocardiography requires multiple views to evaluate the heart completely. Acquisition depends on the operator's skill and the patient's cooperation. The limited ability of a severely neurologically damaged patient to comply with positioning may be a limiting factor.
Intracardiac thrombus may not be present after embolism, and silent emboli may occur. However, the importance of detecting cardiac clot lies in its value to predict systemic embolization, which may be three times the normal risk in the presence of LA thrombus and highly likely in the presence of MI or GWD where LV clot is found.
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- 36 The majority of LV thrombi in this series were seen in patients with MI or GWD, confirming the importance of detecting these abnormalities, which may themselves indicate a site with a high likelihood of thrombus formation. Patient   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39 
UFCT, cardiac ultrafast computed tomography; 2D echo, two-dimensional echocardiography; ECG, electrocardiography; A, multiple, bilateral, superficial and deep; B, superficial only or superficial and deep, unilateral in middle or posterior cerebral artery territory; C, deep and larger than lacunar, unilateral; D, retinal artery occlusions; E, lacunar; F, hemorrhagic; TLS, technically limited study; ND, not performed.
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The importance of MAC as an embolic source for cerebral embolization is uncertain; nevertheless, finding a lower MAC incidence with UFCT, a very sensitive densitometer, suggests that 2D echo, which cannot distinguish calcification from fibrosis, might overdiagnose the condition. 37 - 40 UFCT findings need to be correlated with cardiac and cerebral pathology in patients with stroke to determine if MAC is a source of emboli. The major determinant of morbidity and mortality after ischemic stroke relates to CAD.
3 -5 -41 - 43 Tannenbaum et al 44 have shown a high degree of sensitivity and specificity of CAC as detected by UFCT in predicting hemodynamically significant CAD compared with coronary arteriography. More than half (21) of our 40 patients had CAC identified by UFCT; many had no historical, 2D echo, or ECG evidence of myocardial ischemia. The prognostic significance of CAC in this group of patients is uncertain. The high incidence of CAC in our study may reflect selection bias as we chose patients postulated to have a high probability of cardiac pathology as the etiology for their stroke (Table 3) . Beattie et al 34 recently published preliminary findings comparing 2D echo with UFCT for the detection of intracardiac thrombus in patients with cerebral ischemia. As complete data are not yet available, a full critical comparison of that study with ours cannot be made. It is interesting that Beattie et al report a lower degree of discord between 2D echo and UFCT. This may be explained partially by patient selection; we included only patients with stroke thought at the outset to be due to thromboembolism.
Several points emerge from our preliminary study of the use of UFCT in patients with stroke. First, UFCT appears to enhance the capacity for detecting cardiac sources of embolism and CAD in such patients. Second, because of substantial differences in the UFCT and 2D echo findings, there is a need for pathologic confirmation of intracardiac thrombus by either surgery or necropsy. Finally, certain subgroups of stroke patients may be candidates for evaluation by cardiac UFCT to detect the immediate cause of stroke and to prevent future morbidity and mortality. The incidence of future cardiac and cerebral ischemic events in our selected group of patients needs to be defined and correlated with the presence of CAC and intracardiac thrombus. A larger group of consecutive stroke patients might be studied to better define the interdependence of cerebral and cardiac pathologies.
